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Abstract
Background: De novo eukaryotic promoter prediction is important for discovering novel genes and
understanding gene regulation. In spite of the great advances made in the past decade, recent studies revealed
that the overall performances of the current promoter prediction programs (PPPs) are still poor, and
predictions made by individual PPPs do not overlap each other. Furthermore, most PPPs are trained and
tested on the most-upstream promoters; their performances on alternative promoters have not been assessed.
Results: In this paper, we evaluate the performances of current major promoter prediction programs (i.e.,
PSPA, FirstEF, McPromoter, DragonGSF, DragonPF, and FProm) using 42,536 distinct human gene
promoters on a genome-wide scale, and with emphasis on alternative promoters. We describe an artificial
neural network (ANN) based meta-predictor program that integrates predictions from the current PPPs and
the predicted promoters' relation to CpG islands. Our specific analysis of recently discovered alternative
promoters reveals that although only 41% of the 3′ most promoters overlap a CpG island, 74% of 5′ most
promoters overlap a CpG island.
Conclusion: Our assessment of six PPPs on 1.06 × 109 bps of human genome sequence reveals the specific
strengths and weaknesses of individual PPPs. Our meta-predictor outperforms any individual PPP in
sensitivity and specificity. Furthermore, we discovered that the 5′ alternative promoters are more likely to be
associated with a CpG island.
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Abstract
Background: De novo eukaryotic promoter prediction is important for discovering novel genes
and understanding gene regulation. In spite of the great advances made in the past decade, recent
studies revealed that the overall performances of the current promoter prediction programs
(PPPs) are still poor, and predictions made by individual PPPs do not overlap each other.
Furthermore, most PPPs are trained and tested on the most-upstream promoters; their
performances on alternative promoters have not been assessed.
Results: In this paper, we evaluate the performances of current major promoter prediction
programs (i.e., PSPA, FirstEF, McPromoter, DragonGSF, DragonPF, and FProm) using 42,536
distinct human gene promoters on a genome-wide scale, and with emphasis on alternative
promoters. We describe an artificial neural network (ANN) based meta-predictor program that
integrates predictions from the current PPPs and the predicted promoters' relation to CpG islands.
Our specific analysis of recently discovered alternative promoters reveals that although only 41%
of the 3' most promoters overlap a CpG island, 74% of 5' most promoters overlap a CpG island.
Conclusion: Our assessment of six PPPs on 1.06 × 109 bps of human genome sequence reveals
the specific strengths and weaknesses of individual PPPs. Our meta-predictor outperforms any
individual PPP in sensitivity and specificity. Furthermore, we discovered that the 5' alternative
promoters are more likely to be associated with a CpG island.
Background
Initiation of transcription is regulated by a coordinated
binding of many transcription factors to the core pro-
moter region. The initiation process is further modulated
by binding of activators and repressors in more distal
regions [1,2]. The core promoter is the region (usually ±
50 bps) around the transcription start site (TSS), which is
vital for initiation of the basal transcription. The core pro-
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moter contains several transcription factor binding sites
that facilitate transcription initiation, such as the TATA
box, the GC box, Inr [1,3], and the recently discovered
MTE [4] and DPE [5]. In human, the TATA box is the most
abundant, present in 25–30% of promoters within the
entire genome [3,6]. The process of predicting the core
promoter can therefore be summarized as using these
characteristics to locate the TSS.
To understand eukaryotic transcriptional regulation, accu-
rate identification and localization of core promoters are
important [7]. The difficulty in identifying eukaryotic core
promoters is that unlike in prokaryotes, eukaryotic pro-
moters are sometimes located several hundred kb away
from the translation initiation site (TIS). The eukaryotic
promoters are usually identified by detecting full-length
cDNA, e.g., oligo-capping [8]. However, such experimen-
tal methods are laborious, time-consuming and expen-
sive. De novo computational Promoter Prediction
Programs (PPPs) show great potential in this regard and
have achieved moderate success in the past [9,10]. Never-
theless, promoter prediction at high resolution, especially
for promoters that are not associated with CpG islands
(CpG-poor promoters), remains unsatisfactory [11-14].
It is widely recognized that promoter regions are corre-
lated with CpG islands. CpG islands are regions of DNA
longer than 200 bps with a G+C content of at least 50%,
and the number of CpG dinucleotides being at least 60%
of what could be expected from the G+C content [15,16].
CpG islands are well known to be highly associated with
many mammalian gene promoters (CpG-rich promoter);
about 50~60% of the promoters are associated with CpG
islands [17]. The first generation PPPs, such NNPP [18],
TSSG and TSSW [19], PromFD [20], and PROSCAN [21]
did not use CpG island as a landmark and thus showed
poor results in large-scale evaluations [2]. A consensus
program, CONPRO [22], combined features of these PPPs
and other genomic information for promoter prediction.
Tested on a small dataset, CONPRO showed improve-
ments over individual PPPs. Various other techniques
were also employed with varying success. Homology-
based promoter predictions have achieved moderate suc-
cess [23,12]. PromoterInspector [24] improved prediction
accuracy by allowing variable gaps between fixed oligom-
ers, and implicitly using CpG island information [11].
Zhang's group [25] was the first to classify explicitly the
promoters into CpG-island-associated and the non-CpG-
island-associated. They implemented this notion (i.e.,
using CpG island as landmark) in their recent promoter
prediction program – FirstEF, and achieved significant
improvement [9]. Since then, all the high performing pro-
grams, such as DragonGSF [26], McPromoter [27], and
PSPA [13] use CpG islands as landmarks to make a predic-
tion.
To evaluate fairly the performance of the PPPs, we sepa-
rated promoters into two subtypes – CpG-rich and CpG-
poor, depending on whether they are CpG-island related
or not [28]. To ensure that a CpG-poor promoter does not
relate to any CpG island, we classified each promoter as
follows. If a CpG island is present within the ± 5 kbps
sequence of a promoter, we classified the it as CpG-rich,
otherwise CpG-poor [13,28]. This classification adopts a
more stringent criterion for a TSS being non-CpG-related
(CpG-poor). Thus, in our study, the proportion of CpG-
rich promoters is higher than the previous estimates [12].
Different programs utilize different characteristics of the
genomic sequence near the promoter to make predictions.
For example, DragonGSF and DragonPF use CpG islands
as a global landmark and integrate additional attributes
using an Artificial Neural Networks (ANN) to predict TSSs
within the ± 3700 bps of CpG islands [26,29]. FirstEF first
scans -1,500 to +500 bps to detect a CpG island, then uses
two different quadratic discriminant functions in a -500
to +70 bps window for TSS prediction [9]. These attributes
include the frequencies of fixed-length motifs in different
windows in the -500 to +70 bps region. The FProm pro-
gram uses a linear discriminant function to make predic-
tion based on the characteristics in the -200 to +50 bps
region of the TSS [19,30]. McPromoter focuses on the -
250 to +50 bps region and uses a generalized hidden
Markov model, with six interpolated Markov chain sub-
models representing different segments of the promoter
region [27]. The recently improved version of McPro-
moter classifies drosophila promoters into 5 subtypes and
uses one model for each subtype to make a prediction
[14]. PSPA uses -100 to +100 bps around the TSS and uses
a strict position-specific and variable-length motif pro-
pensity model. It shows a superior performance on CpG-
poor promoters [13]. Based on a large-scale evaluation on
the human genome, a recent review [10] showed that
DragonGSF and FirstEF performed better at a low resolu-
tion (i.e., cutoff at 2000 bps). Another recent evaluation
[13] showed that their performances deteriorated sharply
at a more stringent resolution (cutoff <500 bps). The
study showed that DragonGSF made virtually no predic-
tions on the CpG-poor promoters and FirstEF made no
prediction on 85% of the CpG-poor promoters. Even
though PSPA improved prediction on the CpG-poor pro-
moters, its overall performances on CpG-poor promoters
remained unsatisfactory. A focus on high resolution and
on CpG-poor promoter prediction is needed [10,13].
The previous evaluations [10] were limited to the most
upstream TSS (MUTSS) or the most frequent TSS as
defined by DBTSS database [8]. Recent studies showed
that there were several hundred thousand TSS in the
human and mouse genomes, and 58% of the mammalian
genes have alternative transcription start sites (ATSS) [31].
BMC Genomics 2007, 8:374 http://www.biomedcentral.com/1471-2164/8/374
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The presence of multiple ATSS for a single gene is related
to tissue-specific gene expression. For example, the UDP-
glucuronyl transferase gene has seven alternative promot-
ers, each responsible for expression in a certain type of tis-
sue [31]. The more recent ENCODE region study showed
that the regulatory elements distributed symmetrically
around the TSS, with no bias towards the upstream
regions [32]. As more and more experimentally validated
ATSSs become available, it is necessary to evaluate the
PPPs on all TSSs (termed ATSS, alternative TSS in this
paper), not only the MUTSSs. Furthermore, promoters
predicted by various PPPs do not overlap. At a prediction
resolution of -50 to +50 bps, the correct predictions from
different programs are largely distinct [13]. If a meta-pre-
dictor could combine the correct predictions from each
PPP, it would achieve a much higher performance.
In this paper, we first describe the relationship between
CpG island and promoters. We then evaluate the perform-
ance of PPPs on a large set of ATSS, which includes MUTSS
as well as the other promoters, including the middle TSS
(MTSS) and the most downstream TSS (MDTSS). Finally,
we introduce a meta predictor that combines promoter
predictions from top-performing PPPs using Artificial
Neural Networks, as well as the genomic information
such as CpG island (Figure 1). Our large-scale tests on the
human genome show that the meta predictor is signifi-
cantly superior in terms of sensitivity and specificity, as
compared to the individual PPPs.
Results
Alternative promoters are symmetrically distributed
We used TSS annotations from DBTSS[33] and RefSeq
[34] as our reference. Since DBTSS includes alternative
TSS, we extracted the must upstream TSS as a subset,
named DBTSS 5'. We compared the distance between
MUTSS and the upstream coding sequence (CDS) docu-
mented in these databases and found no significant differ-
ence (Figure 2). Both DBTSS 5' and RefSeq annotated TSSs
were upstream of the CDS, and about 67% were within 1
kb upstream. However, when DBTSS ATSSs were counted,
only 30% of the ATSSs were within 1 kb upstream of CDS,
and the rest distributed symmetrically around this region.
We then integrated the TSSs from the two datasets into
one and clustered them based on their genomic locations.
If twoTSSs are less than 5 bps apart, we take the upstream
one as a representation of the cluster. After removing the
redundant TSSs, we obtained 42,536 distinct ATSS. We
pooled these ATSS together and clustered them into
14,566 clusters (see Methods). For each cluster, we
extracted the region spanning 5 kb upstream of the
MUTSS to the end of the gene (if there were multiple
genes in the cluster, we used the MUTSS of the first gene
and 3' UTR of the last gene). We thus obtained 14,566
sequences, with a total of 1.06 × 109 bps, which equaled
approximately 30% of human genome. These sequences
were used for promoter prediction. Among the 42,536
ATSS, there are 14,566 MUTSS, 13,114 MDTSS, and
14,856 MTSS. The distance distribution among these TSSs
is shown in Additional file 1.
Flowchart illustrating MetaProm prediction and evaluationigure 1
Flowchart illustrating MetaProm prediction and evaluation. For each of the 14,599 sequences, A) six PPPs were used 
to make predictions. The predictions, as well as the genomic context information, were extracted and compiled to 28 features. 
B) The ANN-based MetaProm is trained and tested on these features, the program either accepts or rejects a prediction. C) 
The program pools all accepted predictions and clusters them and takes the most upstream one as meta predictions. D) The 
meta predictions, along with predictions from PPPs, were evaluated.
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Upstream promoters are more frequently associated with 
CpG islands
Since CpG islands play a vital role in promoter prediction,
we analyzed the correlation between CpG islands and
human gene promoters. To illustrate the relationship
between different types of promoters, we classified the
promoters as MUTSS, MDTSS and middle promoters
(MTSS), depending on their locations in the cluster. We
used a less stringent CpG island detection program [35],
which were used in our previous study [13]. Among the
14,566 sequence, the program detected 162,726 CpG
islands. Figure 3 shows the distance between CpG islands
and the three types of ATSS. 74% of the MUTSS were
within a CpG island, approximately 81% were within 500
bps, and about 95% were within 10 kbps of a CpG island.
The numbers for MDTSS were substantially lower, only
41% were within a CpG island and 54% within 500 bps
of a CpG island. The corresponding numbers for all pro-
moters were 55%, 65%, and 94% respectively.
We also used the CpG islands that were annotated in
UCSC genome browser [36] and observed the same pat-
tern (Additional file 2). The database included 20,238
CpG islands in our promoter sequences. Of the MUTSS,
60% were within a CpG island, approximately 70% were
within 500 bps, and about 78% were within 10 kbps of a
CpG island. In contrast, of the MDTSS, only 31% were in
CpG islands, 37% were within 500 bps, and 54% within
10 kbps.
Statistics of promoter prediction by individual PPP
The 14,566 sequences were used for promoter prediction
by each PPP. We obtained a total of 339,960 TTS-predic-
tions from six PPPs. We then classified the predictions
into two categories. If a prediction was within ± 5 kb of a
CpG island, it was classified as a CpG-rich prediction oth-
erwise a CpG-poor prediction. The classification resulted
in 247,540 (72.8%) CpG-rich predictions and 92,420
(27.2%) CpG-poor predictions. The composition of the
predictions contributed by each PPP was shown in Table
1. FProm made the majority of the predictions, 77% of the
total CpG-rich predictions and 92% of the CpG-poor pre-
dictions. Each of the other PPPs made about 5% of the
Distance between Transcription Start Site (TSS) and CpG islandFigure 3
Distance between Transcription Start Site (TSS) and 
CpG island. ATSS: all promoters; MUTSS: most upstream 
promoter (most 5' promoter); MTSS: middle promoter; 
MDTSS: most downstream promoter. Zero distance indi-
cates the TSS is within the CpG island. The number in longer 
distance includes that in the short distance. MUTSS has 80% 
more chance to be in CpG island than MDTSS.
Histogram of distances between Transcription Start Site (TSS) and Coding Start (CDS)Figure 2
Histogram of distances between Transcription Start 
Site (TSS) and Coding Start (CDS). ATSS: based on 
30,964 Alternative TSS from DBTSS database; RefSeq: based 
on 25,647 TSS from RefSeq database; DBTSS 5': based on 
14,628 most upstream TSS from DBTSS database, a subset of 
ATSS. All data are binned by size of 1 kb, with registered on 
the x-axis by the middle point. Positive values in the x-axis 
indicate TSS is upstream of CDS. Note that there is no signif-
icant difference between RefSeq and DBTSS 5'. ATSS from 
DBTSS is present both up- and down-stream of CDS, with a 
symmetrical distribution around the bin of 500.
Table 1: The proportion of predictions made by each promoter 
prediction program.
PPP CpG-rich CpG-poor
DragonGSF 4.13% 0.00%
DragonPF 3.91% 0.58%
FirstEF 4.42% 0.00%
FProm 76.58% 92.29%
McProm 4.83% 0.09%
PSPA 6.13% 7.04%
With total 339,960 predictions in 30% of human genome by six PPPs, 
247,540 (72.8%) are CpG-rich predictions and 92,420 (27.2%) are 
CpG-poor predictions.
BMC Genomics 2007, 8:374 http://www.biomedcentral.com/1471-2164/8/374
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total CpG-rich predictions. Three PPPs, DragonGSF,
FirstEF and McPromoter made few CpG-poor predictions.
We then looked at the average number of predictions
made by each PPP per promoter. As shown in Table 2,
FProm was very lenient in making predictions; it made on
average five predictions for each CpG-rich promoter and
18 predictions for each CpG-poor promoter. The other
five programs were comparable on CpG-rich promoters.
On average, they make about 0.25 to 0.4 predictions per
true CpG-rich promoter. On CpG-poor promoters, PSPA
made about 1.4 predictions per true CpG-poor promoter,
and DragonPF made about 0.11 predictions.
Performance evaluation of individual PPP
We evaluated the performance of six PPPs on CpG-rich
and CpG-poor promoters separately. The sensitivity and
specificity of each PPP were reported at three levels of res-
olution – high (50 bps), intermediate (200 bps) and low
(2000 bps). All the predictions were subject to the same
evaluation criteria and the results were shown in Figure
4A–F.
For CpG-rich promoter evaluations, we added a baseline
prediction as a control. To perform the baseline predic-
tion, we picked a random location near each CpG island
(defined as such in the UCSC genome browser) [37], and
used it as a prediction. A total 20,238 random predictions
were evaluated by the same criteria as other PPPs, and sen-
sitivity, specificity were reported. To evaluate the variation
of the random baseline prediction, we repeated the proc-
ess 10 times. The standard deviations for sensitivities and
specificities were also reported in the figure legend. Figure
4A–C showed the performance of six PPPs and the base-
line prediction on CpG-rich promoters. PSPA and FirstEF
performed better at high resolution, whereas FirstEF and
DragonGSF performed better at low resolution. FirstEF,
PSPA and McPromoter performed better at intermediate
resolution. FProm had a higher sensitivity, but a lower
specificity at all resolutions. FirstEF and PSPA both per-
formed relatively well with a balanced sensitivity and spe-
cificity. The baseline prediction, though randomly
selected within a CpG island, performed very consistently,
with standard deviation of only ± 0.0% to ± 0.3% for both
sensitivity and specificity.
We evaluated the performance of DragonPF, FProm and
PSPA on CpG-poor promoters (Figure 4D–F). We
excluded other PPPs from this evaluation because they vir-
tually did not make predictions on the CpG-poor promot-
ers. In general, the performance on CpG-poor promoter
was much lower than that of the CpG-rich promoter. At a
low resolution, DragonPF showed a higher specificity and
FProm a higher sensitivity. PSPA showed a higher sensitiv-
ity at high resolution and had a balanced sensitivity and
specificity in all ranges of resolutions.
To evaluate the similarity of these PPPs, we compared the
correct predictions from each pair of PPPs at medium res-
olution (200 bp) and the results were shown in Tables 3
and 4. The overlaps in CpG-rich promoter (Table 3) were
substantially larger than that of the CpG-poor (Table 4).
For promoter predictions in CpG-rich sequences, FProm
and DragonPF had the highest overlap at 81%, and
McPromoter and DragonGSF had the lowest at only 38%.
For promoter prediction in CpG-poor sequence, FProm
and PSPA had the highest overlap at 26%, and FirstEf and
FProm had the lowest overlap at 12%. The overlaps at
high and low resolutions were shown in Additional file 3.
With less restricted resolutions, we observed a sharp
increase of overlaps from the high to low resolutions for
CpG-rich sequences. The overlaps are 11%~52% for the
high resolution, 38%~81% for the medium resolution,
and 66%~89% for the low resolution. However, the trend
was not as significant for the CpG-poor sequences, where
predictions overlapped at 6%~32%, 12%~31%, and
18%~35% for the high, medium and low resolutions,
respectively.
CpG islands is key to prediction accuracy
Another notable feature in Figure 4 was that the baseline
prediction, particularly at the low resolution, performed
as well as the other PPPs. This result showed the power of
using CpG-islands as a landmark for promoter prediction,
and how current PPPs relied on CpG island critically. Even
though they would miss the promoters that were not asso-
ciated with CpG islands, PPPs that made prediction exclu-
sively on regions near CpG islands were bound to perform
better than those PPPs that did not use CpG islands as a
landmark.
The promoter prediction problem was much harder for
CpG-poor sequences. Since there was no CpG island to
serve as the landmark, the PPPs had to consider a much
larger region for prediction. An alternative approach was
to use the feature of a gene as a landmark, since gene pre-
Table 2: Average predictions per true promoter by each promoter prediction program.
DragonGSF DragonPF FirstEF FProm McProm PSPA
CpG-rich 0.27 0.26 0.29 5.02 0.32 0.40
CpG-poor 0.00 0.11 0.00 17.96 0.02 1.37
BMC Genomics 2007, 8:374 http://www.biomedcentral.com/1471-2164/8/374
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diction programs use context information derived from a
higher degree of conservation in the encoding region. It
was shown that integration of gene prediction and EST
information improved promoter prediction [22,38]. A
recent study [13] showed that CpG-poor promoters were
more conserved and had fewer alternative start sites than
the CpG-rich promoters. This observation was further
confirmed [31,39]. The observation implied that the sig-
Performance of PPPs on genome-wide predictionFigure 4
Performance of PPPs on genome-wide prediction. A, B, C: PPPs' performances on CpG-rich sequence at A) high (50 
bp), B) medium (200 bp) and C) low (2 kbp) resolution, respectively. D, E, F: Performances on CpG-poor sequence at D) high 
(50 bp), E) medium (200 bp) and F) low (2 kbp) resolution, respectively. The performance is measured by sensitivity, which is 
the proportion of all true promoters that are predicted correctly, and specificity, which is the proportion of total prediction 
that are correct. The evaluation was based on 37,793 CpG-rich promoters and 4,743 CpG-poor promoters on 1.06 × 109 bps 
of the human genome. For baseline prediction, we repeated the randomization (see text) 10 times and the means are reported. 
The standard deviations (sensitivity, specificity) are (± 0.2%, ± 0.3%), (± 0.2%, ± 0.2%), (± 0.0%, ± 0.1%) for the high, medium 
and low resolutions, respectively.
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nal around CpG-poor promoters was stronger, and was
independent of CpG islands. The promoter prediction on
CpG-poor promoters was thus likely to be more accurate.
However, most state-of-the-art PPPs used CpG islands as
a primary landmark, which reduced the search scope by
about 50-fold. As a result, prediction accuracy on CpG-
rich promoters was far higher than that on the CpG-poor
promoters.
Evaluation of MetaProm
Next we used a neural-network-based approach to inte-
grate the predictions made by individual PPPs to improve
the overall prediction accuracy. We included the perform-
ance of the different PPPs at the intermediate resolution
of 200 bps. The performance of MetaProm was based on
10-fold cross-validation. The sensitivity~specificity coor-
dinate of each PPP was shown in Figure 5. MetaProm was
effective on CpG-rich promoter prediction. At a specificity
of 60%, MetaProm boosted the sensitivity from 26% to
46% as compared to FirstEF. At a specificity of 50%, it
improved the sensitivity from 29% to 52% as compared to
PSPA. On CpG-poor promoter predictions, MetaProm
made only marginal improvements upon the current best
performer, PSPA [13]. This was because only three pro-
grams make predictions on CpG-poor promoters, and
they made very few predictions. The evaluations of Met-
aProm at the high and low resolutions were shown in
Additional file 4.
Discussion
It is widely recognized that promoter regions are corre-
lated with CpG islands. CpG islands were originally found
around TSSs in about 55% of the human promoters,
based on hundreds of experimental screening of human
genes [40]. Since then, CpG islands have been used as
landmarks in many promoter prediction programs
[9,29,27,13]. Recent large-scale oligo-capping of full-
length cDNA techniques provided a large set of experi-
mentally validated promoter data, which enable us to
evaluate the links between CpG islands and promoters in
much greater detail [31]. Using an older version of RefSeq,
previous study showed that 34% of the RefSeq annotated
TSSs could be extended towards the 5' ends [8]. Here we
used a recent version of RefSeq database [41], which was
substantially enhanced and includes most of the TSS from
DBTSS. Our study showed that there was not a significant
difference between the RefSeq and DBTSS MUTSS annota-
tions in terms of distance to the translation start site.
Since the discovery of the close association between CpG
islands and promoters, this association has been widely
utilized for promoter and gene prediction. Previous stud-
ies showed that about 50~60% of the promoters are asso-
ciated with CpG islands[17], we found the association is
stronger. By using a recently developed CpG island calcu-
lation program [35], we showed that more than 65% of all
promoters are within 500 bps of a CpG island, and 95%
of all promoters are within 10 kbps of a CpG island.
Table 4: Pair-wise overlaps of correct predicted promoters between two PPPs at medium (200 bp) resolution for the CpG-poor 
promoters.
PPP (correct predictions)
DragonPF (199) FirstEF (183) FProm (789)
PPP (correct 
predictions)
FirstEF (183) 15% (28)
FProm (789) 27% (134) 12% (56)
PSPA (629) 19% (80) 26% (104) 31% (223)
Table 3: Pair-wise overlaps of correct predicted promoters between two PPPs at medium (200 bp) resolution for the CpG-rich 
promoters.
PPP (correct predictions)
DragonGSF (7,205) DragonPF (18,959) FirstEF (15,015) FProm (20,884) McProm (7,891)
PPP 
(correct predictions)
DragonPF (18,959) 49% (6,380)
FirstEF (15,015) 44% (4,890) 75% (12,795)
FProm (20,884) 45% (6,310) 81% (16,084) 70% (12,632)
McProm (7,891) 38% (2,870) 52% (6,918) 49% (5,636) 49% (7,051)
PSPA (11,164) 47% (4,313) 67% (10,091) 67% (8,750) 61% (9,806) 48% (4,534)
The number in parenthesis is the count of correctly predicted promoters; the percentage number is calculated by the count of the overlap divided 
by the mean of both PPPs. The overlaps at high and low resolutions are shown in Additional file 3.
BMC Genomics 2007, 8:374 http://www.biomedcentral.com/1471-2164/8/374
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More importantly, we found that the 5' alternative pro-
moters were more closely linked to CpG islands than the
3' promoters of the same gene. Consistent with the role of
CpG islands in the recruitment of chromatin modification
enzymes, it is conceivable that the most upstream pro-
moters represent the broadly used substrate in a hierarchi-
cal regulation of gene transcription, whereas the
downstream, non-CpG-associated promoters are used in a
tissue-specific fashion in conjunction with the upstream
promoters. We hypothesize that most polymerase II tran-
scription complexes are assembled at the vicinity of a CpG
island. It then either starts transcription, or slides to
another active promoter to initiate transcription.
Our results also showed that improvements on CpG
island prediction can further reveal the relationship
between CpG islands and promoters. Since the new CpG
island program detects substantially more CpG islands,
not surprisingly, we found more promoters are associated
with CpG islands. It also provides us a challenge to
develop CpG island detection programs that can help
identify promoters. We believe this is especially important
in the current context of DNA methylation and histone
modification studies [42,43]. The CpG island detection
program will give us more opportunity to understand not
only genetics, but also the epigenetic regulation of genes.
Similar to the discovery of the higher proportion of pro-
moters associated with CpG islands, we might find that
more DNA methylation and histone modification events
are associated with CpG islands.
Different PPPs capture different characteristics of mam-
malian core promoters. Because most PPPs are based on
machine learning approaches, the genomic attributes cap-
tured by the PPPs are not thoroughly investigated. These
attributes will be important in understanding mamma-
lian promoters and in return help us to develop a better
PPP. As a first step, we propose a MetaProm tool that inte-
grates the predictions by individual PPPs using an artifi-
cial neural network. By combining these predictions, our
MetaProm showed significant improvement over the indi-
vidual PPPs. Liu and States [22] have developed a consen-
sus method -CONPRO. The authors were able to improve
the prediction accuracy by combining results from five
PPPs and one gene prediction program. However, the five
PPPs (NNPP [18], TSSG and TSSW [19], PROSCAN [21]
and PromFD [20]) used were shown to perform poorly
[44]. In contrast, the PPPs used in our meta-predictor are
relatively new and all are different from the ones CON-
PRO used, except FProm, which is an improved version of
TSSG.
Several reasons contribute to MetaProm's lack of improve-
ment on CpG-poor promoter prediction. First, only three
PPPs make predictions on this type of promoters and the
number of predictions is much lower comparing to the
CpG-rich promoters. Second, the overlaps between the
three PPPs are also substantially lower than that of CpG-
rich promoters. Third, the proportion of overlap does not
increase as we go from a high resolution to a low resolu-
tion (Table 4). Since MetaProm does not make new pre-
dictions, it relies on the context information from other
PPPs in the surrounding region. For CpG-rich promoters,
the overlaps are as high as 80% in medium and low reso-
lution, and the model can use context information from
other predictions and thus works better. However, for
CpG-poor promoters, 1) we do not have sufficient predic-
tions to use and 2) these predictions usually do not over-
lap in the 2 kb base pair region, which is the maximum
context information that our model uses. Therefore, the
improvement is not significant.
The recent large-scale determination of full length cDNAs
has generated large amount of reliable promoter data, and
has led to some novel insights. For example, recent data
Evaluation of MetaProm at medium resolution on genome-wide pr m ter predictionFig re 5
Evaluation of MetaProm at medium resolution on 
genome-wide promoter prediction. A) On CpG-rich 
promoters; B) On CpG-poor promoters. The evaluations of 
MetaProm are based on the 10 cross-validation. The evalua-
tions on the high and middle resolutions are shown in Addi-
tional file 4.
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shows that 58% of genes have multiple alternative start
sites and these often correspond to tissue-specific expres-
sion of the transcript [31]. In this study, we have included
alternative TSS to evaluate the current PPPs for the first
time. Not surprisingly, as more and more annotated TSSs
are considered, we get higher specificity and lower sensi-
tivity. We are aware that most PPPs were trained and
tested only for MUTSS prediction, which may underesti-
mate their performances. However, since the biological
paradigm is shifting from one gene, one promoter to one
gene, multiple promoters, it also imposes computational
challenge to the promoter prediction field.
Even though the large-scale experimental data provide us
with a large number of cDNAs, these cDNAs are by no
means comprehensive and exhaustive. Some false positive
predictions by the MetaProm program might prove to be
true positives once the experimental detection of promot-
ers becomes more sensitive. The core promoter prediction
programs also provide a basis for designing the whole-
genome promoter array. Furthermore, algorithms that are
successful on human promoter prediction can hopefully
be used in other mammalian genome promoter predic-
tion, and thus guide experimental studies.
Previous evaluation on MUTSS reports greater variability
of the performance on different chromosomes [10]. Our
evaluation on ATSS shows that most PPPs have consistent
performance on different chromosomes (data not
shown). Every PPP seemingly captures slightly different
attributes of the promoter sequences and thus makes pre-
dictions that are largely unique to the PPP [13]. A recent
paper discussed extensively the attributes used by each of
these PPPs [38]. DragonPF, DragonGSF and firstEF incor-
porate both promoter region and part of gene structure to
make a prediction, and thus require a relatively longer
sequence (>500 bps). FProm, McPromoter and PSPA use
shorter sequences (<250 bps) flanking the promoter
region to make predictions. They do not depend on pro-
tein-coding region thus can be used in predicting RNA
gene promoters. Until we gain a better understanding of
the biological signals encoded in the promoter regions
that are recognized by the transcriptional machinery, our
machine-learning approach to integrate the predictions
made by different PPPs will provide a valuable resource.
While this manuscript was under review, another pro-
moter prediction program [45] was published, with focus
on non-CpG-related promoter prediction. The program
adopted a LogitBoost procedure to make prediction based
on features such as position-specific elements, TFBS, and
k-mer frequencies. This study differs from our study in the
following: 1) Similar to other state-of-the-art PPPs, this
study focuses on MUTSS prediction, whereas our study
focuses on ATSS prediction; 2) the assessment of the pro-
gram is performed on a limited length of sequence (2.4 kb
around the annotated TSS). We focus on the whole
genome prediction, with about 30% of the human
genome sequences; 3) the assessment is based on a
smaller dataset (trained and tested on 3,210 CpG-related
promoters and 1,576 non-CpG-related promoters). Our
study uses 37,793 CpG-rich promoters and 4,743 CpG-
poor promoters. This new program gains significant
improvement on both CpG-related and non-CpG-related
promoter predictions. Incorporating this PPP into our
meta predictor has the potential to improve overall pre-
diction performance.
Conclusion
Our genome wide evaluation was based on all available
promoters, including alternative promoters. We discov-
ered that promoters at the 5' end of the gene are more
likely to be linked to a CpG island. Evaluation based on
the human genome shows that MetaProm performs better
than any of the individual PPP both in terms of sensitivity
and specificity. This meta prediction method should be
useful in locating the promoter region of a gene, and thus
facilitating the analysis and understanding of gene regula-
tion. The MetaProm program and the genome wide pre-
dictions are available upon request.
Methods
Dataset
We retrieved the coordinates of full-length cDNA
sequences from the DBTSS [8] and RefSeq [34] databases,
and mapped them to the human genome (version hg17).
The sequences in DBTSS are comprised of full-length
cDNA transcripts, whose 5' ends are experimentally deter-
mined [33]. The sequences in RefSeq are primarily from
the GenBank repository and are manually-curated full-
length cDNAs [41]. These two datasets are standards in
genomic annotation and promoter analysis. In the latest
version of DBTSS "near-by" genes are clusters into groups
[33]. Each cluster contains one or more alternative TSS,
and many groups contain multiple transcripts or genes (a
transcript is defined by a unique 'NM' id). For each NM id,
we also find the TSS annotated by RefSeq, and treat them
as additional ATSS if they are more than 5 base pairs apart
from the DBTSS annotation. The final dataset contains
14,566 groups (clusters) with 42,536 distinct ATSS. For
each group, we extracted the genomic sequence that spans
from 5 kbs upstream of the MUTSS to the end of the gene
(end of 3' UTR). The sequence length varies from 5,243
bps to more than 2 million bps, with a combined
sequence length of 1.06 × 109 bps, or about 30% of the
human genome. Among these sequences, only 326
(2.2%) sequences do not contain any CpG island.
Out of 42,536 total ATSS, we have 37,793 (88.9%) CpG-
rich promoters and 4,743 (11.1%) CpG-poor promoters;
BMC Genomics 2007, 8:374 http://www.biomedcentral.com/1471-2164/8/374
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this proportion is similar to the that of MUTSS [13]. CpG
islands are defined as GC enriched sequences of >200 bps,
G+C content >50% and CG di-nucleotide ratio >0.6. We
used a CpG island detection program based on [35],
which adopted new criteria for CpG islands; these criteria
result in more genes being associated with CpG islands.
We separated the promoters into three groups based on
their position in the cluster, the MUTSS, the MDTSS, and
if there are more than two promoters in the cluster, we
name them MTSS. All the promoters are called alternative
promoters (ATSS). For the promoter-CpG island associa-
tion study, we also downloaded the CpG island data from
UCSC genome browser [37], which adopted a traditional
definition of CpG islands and includes fewer CpG islands.
Promoter predictions and parameter selection
Promoters are predicted on each sequence by individual
PPP with default parameter settings as described in
[10,13]. Briefly, the parameter settings for individual PPP
are as following:
DragonGSF: threshold 0.994 (default)
DragonPF: sensitivity 0.65
FirstEF: default setting of P(Exon)>0.5, P(Donor)>0.4,
and P(Promoter)>0.4.
McPromoter: threshold = -0.05
FProm: default setting
PSPA: score cutoff = 100 for CpG-rich, and cutoff =
150 for CpG-poor.
Similar to the classification for real promoters, we classi-
fied each predicted TSS into CpG-rich or CpG-poor based
on whether there is a CpG in the surrounding ± 5 kbps
region. The performances of individual PPPs are evaluated
separately on CpG-rich and CpG-poor predictions. We
also added a baseline prediction as control for CpG-rich
promoter prediction. In each of the annotated CpG island
[37] in the 14,566 sequences, we randomly choose a loca-
tion within the CpG island as a prediction. The baseline
predictions were subjected to same evaluation as other
PPPs. We repeated the baseline prediction 10 times. The
mean and standard deviation of the sensitivity and specif-
icity were also reported.
Evaluation of the predictions
We adopted the evaluation approach as previously
described [10]. Because the promoter annotation is not
complete, we do not know if the predictions in intergenic
region are false positives, we only evaluate the predictions
that fall within 2 kbs upstream of the MUTSS and the end
of the gene (we call them valid predictions). A prediction
is considered correct if it is ± L bps away from any of the
annotated ATSS. We focus on three values of L in this
study, 2000 bps to test the performance at low resolution,
200 bps to test at intermediate resolution, and 50 bps to
test the performance at high resolution. The performances
of PPPs are evaluated based on sensitivity and specificity.
Sensitivity = (correctly predicted promoters)/(total
number of promoters, including all ATSSs), Specificity
(ppv) = (correct predictions)/(valid predictions). Since
there can be more than one ATSS in a sequence, here a
promoter is defined for an individual ATSS, not for a
sequence (group or cluster). The pair-wise overlap of pre-
dictions by two PPPs, A and B, is calculated by OAB = (CAB
× 2)/(CA + CB), where is the number of correct predicted
ATSS by both A and B, CA, CB are the numbers of correctly
predicted ATSSs by A and by B, respectively.
Features extracted for MetaProm
For each prediction, the MetaProm program makes a deci-
sion on how reliable the prediction is. The decision is
based on the features we extracted from the genomic con-
text, the prediction itself and the other two closest predic-
tions in the surrounding region, either by the current PPP
or by other PPPs. We observed that for the CpG-rich pro-
moters, the overlap of correct predictions between PPPs
increased rapidly from 50 bp resolution to 200 bp resolu-
tion and further to 2 kb resolution (Table 3 and Addi-
tional file 3). This implies that even though there is a
small chance that two PPPs will predict the same location
as a promoter, there is a greater chance that the different
PPPs will make a prediction in the relative vicinity. Inte-
grating other genomic information, such as the presence
of a CpG island, the GC content, the CpG dinucleotide
content and the length and location of the CpG island,
allows the Artificial- Neural-Net-based model to make a
better prediction.
We classified all predictions into 247,540 (72.8%) CpG-
rich and 92,420 (27.2%) CpG-poor predictions. The two
groups were trained and tested separately. For each predic-
tion from any PPP, a total of 28 features were extracted
from the individual prediction and its surrounding pre-
dictions. The MetaProm used these features to calculate
the likelihood of this prediction to be true (Figure 1). The
detailed descriptions of the features are given in Addi-
tional file 5. These features fall in three classes:
Features of the current prediction: which PPP made the
prediction, the prediction score, is the prediction CpG-
rich or CpG-poor. For some PPPs that do not provide pre-
diction scores, we use the rank value.
Statistics on neighboring predictions: for example, how
many predictions are made by other PPPs within a certain
BMC Genomics 2007, 8:374 http://www.biomedcentral.com/1471-2164/8/374
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distance (50, 100, 500, 1 k, 2 k bps) away from current
prediction. We also used the attributes of the closest pre-
diction by any of other PPPs, such as which PPP makes the
prediction, whether the prediction is CpG-rich or CpG-
poor, the prediction score, and distance from current pre-
diction. We also use the same attributes of the second
closest prediction.
Finally, we used the attributes of the closest CpG island
(or no CpG island for CpG-poor predictions). These
include the length of the CpG island, G+C content, GC
observed expected ratio, whether the prediction is in the
CpG island, or 100, 200, 500, 1 k, 2 k, 5 k bps away from
the edge of the closest CpG island and the distance of the
prediction from closer side of the CpG island, farther side,
and central of the CpG island.
The MetaProm prediction
The MetaProm does not make new predictions, it recalcu-
lates score (probability) of each predicted promoter of
being real. Every prediction from each individual PPP,
along with their features, was used as one instance to the
MetaProm Artificial Neural Network (ANN) model for
training and testing. We used the MultilayerPerceptron
function in the Weka package [46] to perform a 10-fold
cross-validation using a back-propagation algorithm. We
used a three layered structure (input, hidden and output
layer). The input layer had 28 nodes (corresponding to 28
features as shown in Additional file 5) and the hidden
layer had 15 nodes. The following parameter settings were
used for both training and testing; learning rate 0.3,
momentum rate 0.2, number of epochs 500, number of
nodes in hidden layer is (input nodes + labels)/2.
The prediction accuracy for the MetaProm is obtained by
the 10-fold cross-validation: the dataset is partitioned into
10 equal parts, and the ANN model is iteratively trained
on nine parts and tested on the remaining part. The pre-
dictions with an ANN score above the cutoff (selected
based on ROC curve) were taken as positives, and were
clustered if they were within 5 bps with each other. The
prediction with the highest ANN score in the cluster was
selected as the final prediction. To draw the sensitivity-
specificity curves of the MetaProm prediction, we pooled
predictions from the 10-fold cross-validation and ranked
the MetaProm prediction scores (probabilities), and
selected different cutoffs to get the Sensitivity-Specificity
pairs at that cutoff. Since we were not able to obtain the
training versions of PPPs other than our own PSPA, we
could only obtain one Sensitivity-Specificity pair for each
predictor, where the cutoffs were pre-determined by the
individual developer.
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